Cohort studyindependent cross-checkabstract checked I-UPF-119 standard review

Food preservatives, blood pressure and heart disease

Preservative food additives, hypertension, and cardiovascular diseases: the NutriNet-Santé study.

Overview

Hasenböhler A et al.. Eur Heart J 2026 · PMID 42161430 · DOI 10.1093/eurheartj/ehag308

People with higher preservative intake had more high blood pressure and somewhat more cardiovascular disease in a French cohort.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

To link preservatives with blood pressure and CVD.

How was the study done?

Cohort study.

How many people, animals or samples were studied?

112,395 adults.

What was actually found?

More hypertension and CVD with higher preservative intake.

How large was the observed effect?

Hypertension HR 1.29; CVD HR 1.16.

What do the results mean in everyday life?

A signal worth checking.

What are the study's limitations?

Observational; same cohort.

What does it say about Elawady's specific claim?

Contradicts C-UPF-11.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Cannot prove causation.

Scientific in-depth review

1. Full reference

Authors
Hasenböhler A et al.
Journal
Eur Heart J
Year
2026
Identifier
PMID 42161430 DOI 10.1093/eurheartj/ehag308 · PMC13690824
Verification
verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

No COI statement in PubMed record; funding listed: European Research Council, European Union's Horizon, French Ministry of Health, French Network for Nutrition And Cancer Research, Institut National de la Santé et de la Recherche Médicale, Sorbonne Paris Nord University

2. Research question

Are preservative food additives associated with hypertension and CVD?

3. Study design and population

Study design
Cohort study – Prospective cohort (NutriNet-Sante)
Population

French adults (78.7% women; mean age 42.8)

Country

France

Period

2009-2024; median follow-up 7.9 years

Sample size

112,395; 5,544 hypertension and 2,450 CVD cases

Inclusion and exclusion criteria

NutriNet-Sante participants

4. Methods and endpoints

Exposure / intervention

Cumulative time-dependent preservative exposure

Comparator

Lower consumers

Endpoints

Incident hypertension and CVD

Statistical methods

Multi-adjusted Cox models; multiple-testing correction

5. Actual results

Results

Total non-antioxidant preservatives: hypertension HR 1.29 (1.20-1.39); CVD HR 1.16 (1.04-1.29). Total antioxidant preservatives: hypertension HR 1.22 (1.13-1.31). Of 17 individual preservatives, eight associated with hypertension and one with CVD after multiple-test correction.

Absolute risks

not reported in abstract

Authors' conclusion

Multiple associations with hypertension or CVD; experimental research needed; if confirmed, regulations should be re-evaluated.

6. Strengths

  • Detailed exposure

7. Weaknesses

  • Observational; same cohort
  • Antioxidant preservatives (e.g. vitamin C/E) also associated - possible confounding

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Abstract only.

9. Assessment of the statistical interpretation

Moderate HRs; same cohort.

10. Relevance to the specific claim

Third outcome from the same cohort; challenges 'little health concern'.

11. Independent contrary findings

Not independent of I-UPF-117/118.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Signal; needs replication.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidenceunknown
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Replication.

15. Linked fact checks